Morning Breakouts

Latest California Healthline Stories

NIH Rejects Request To Override Abbott’s Norvir Patent

NIH on Wednesday rejected a request from the consumer group Essential Inventions to override patents on Abbott Laboratories’ antiretroviral drug Norvir to allow the production of a generic version of the drug, “effectively allowing” Abbott’s recent 400% price increase for the drug to stand, the AP/ABCNews.com reports.